REPLIGEN CORP — Director's Dealing 2022

Aug 2, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2022-08-01

Reporting Person: Snodgres Jon (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-08-01	Common Stock	S	2000	$220.00	Disposed	37187	Direct

Footnotes

F1: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on March 9, 2022.